Doctor loses RM880,000 in fake share investment scam
A doctor in Pahang lost over RM880,000 in a fake share scheme promising high returns
简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:The Cyprus Securities and Exchange Commission (CySEC) has officially withdrawn the Cyprus Investment Firm (CIF) licence of Arumpro Capital Ltd. The decision was finalised during a CySEC meeting on 11 November 2024, marking another chapter in the firm's ongoing regulatory challenges.

In a significant regulatory development, the Cyprus Securities and Exchange Commission (CySEC) has officially withdrawn the Cyprus Investment Firm (CIF) licence of Arumpro Capital Ltd. The decision was finalised during a CySEC meeting on 11 November 2024, marking another chapter in the firm's ongoing regulatory challenges.
The withdrawal of the licence is in accordance with section 8(1)(a) of the Investment Services and Activities and Regulated Markets Law of 2017, as well as section 4(7) of the Directive DI87-05. According to CySEC, the firm voluntarily renounced its authorisation, prompting the regulatory body to act in compliance with established legal procedures.
This announcement comes nearly three years after Arumpro Capital Ltd faced scrutiny in the United Kingdom. In January 2022, the Financial Conduct Authority (FCA) revoked the firm‘s Part 4A permission, effectively prohibiting it from conducting regulated activities in the UK. The FCA’s decision followed Arumpros failure to address multiple requests for essential information, particularly those outlined in the Temporary Permissions Regime (TPR) Attestation Survey.
The FCA‘s investigation revealed critical shortcomings in Arumpro’s operations. The firm was found to be in breach of the suitability and effective supervision Threshold Conditions. The UK regulator concluded that Arumpro did not meet the criteria to be considered “fit and proper” and lacked the necessary framework for effective supervision. These findings raised serious concerns about the firm's ability to maintain the standards required of entities operating in regulated markets.

The renouncement of its CIF licence by Arumpro further underscores its regulatory struggles. Voluntary licence withdrawals are not uncommon in cases where firms face mounting compliance pressures or operational challenges that hinder their ability to adhere to regulatory requirements. By surrendering its authorisation, Arumpro has effectively ceased its operations as a regulated entity in Cyprus, a jurisdiction known for its stringent oversight of financial services providers.

Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.

A doctor in Pahang lost over RM880,000 in a fake share scheme promising high returns

FIBO Group has grabbed attention from traders for mostly the wrong reasons, as traders have accused the broker of causing financial losses using malicious tactics. Whether it is about withdrawal access, deposit disappearance, trade manipulation, or awful customer support service, the broker is receiving flak from traders on all aspects online. Our team accumulated a list of complaints against the FIBO Group broker. Let’s screen these with us in this FIBO Group review article.

Do you have to pay taxes or margin when seeking fund withdrawals from GMO-Z.com, a Thailand-based forex broker? Do you witness heavy slippage when trading on the broker’s platform? These are some complaints traders have made against the broker. In this GMO-Z.com review article, we have explained these complaints. Take a look!

EOBroker Review shows a low WikiFX score of 1.33/10. No regulation, fake license, and unsafe trading make this broker dangerous.